The Innovation Studio

The Innovation Studio describes its strategy as spanning early-stage startup investing, growth and expansion capital, late-stage venture, and complex situations. The inclusion of complex situations alongside traditional venture and growth equity suggests the firm may engage in distressed investing, turnarounds, or special situations. Specific allocations or fund structures have not been publicly disclosed, so the balance between these mandates is unclear.

The Innovation Studio has not publicly disclosed its principals, founders, or investment committee members on its website or through regulatory filings. Given its Franklin, Tennessee location and private equity focus, its leadership likely includes professionals with backgrounds in Southeastern investment firms, healthcare operations, or technology entrepreneurship. Further details are unavailable from public record.

No. The firm does not publish an AUM figure, nor has a specific fund size been reported by any financial publication. As a private equity firm not subject to public reporting requirements, it is under no obligation to disclose this information. The scale of its investment activity cannot be independently verified.

The firm's sourcing model is not publicly described. Given its location in the Nashville metropolitan area, it likely draws from regional deal flow in healthcare, enterprise technology, and Southeastern growth-stage companies. Whether it relies on proprietary origination, intermediary networks, or co-investor relationships has not been documented.

The firm has not published a formal geographic mandate. Its Franklin, Tennessee headquarters places it in one of the fastest-growing markets for healthcare and technology startups in the United States. However, the absence of a stated regional restriction means it may pursue opportunities nationally, particularly in sectors where the Nashville ecosystem provides a competitive advantage in evaluation.